Delivery Order HHSN272201700051I-75N93019F00132

Award Date 4/30/19
Potential Completion Date 3/31/26
Potential Value $174K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a delivery order contract to The Emmes Company LLC, a for-profit limited liability company, to provide clinical monitoring services for the Vaccine Research Center Clinical Monitoring Initiative. The $147,261.22 delivery order is part of a larger indefinite delivery contract vehicle titled "VRC Clinical Monitoring Initiative 2017-2024" that supports...
This is a delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to The Emmes Company LLC, a global clinical research organization. The contract is part of the Vaccine Research Center (VRC) Clinical Monitoring Initiative 2017-2024, a large multiple-award contract vehicle. The contract provides clinical monitoring services for VRC research projects, with a period of performance from June 24, 2019 to June 23, 2022...
This is a delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to The Emmes Company LLC, a for-profit limited liability company. The contract, which has a potential value of $135,161.86, is for clinical monitoring services in support of the Vaccine Research Center (VRC) Clinical Monitoring Initiative 2017-2024. This is not a set-aside contract. The Emmes Company, a global clinical research organization, has provided...
This is a delivery order for the Vaccine Research Center Clinical Monitoring Initiative, issued by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The $95,996.11 task order was awarded to the prime contractor, The Emmes Company LLC, a for-profit limited liability company that specializes in providing data management, statistical analysis, and clinical trial support services to federal agencies,...
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) to The Emmes Company LLC, a global clinical research organization. The $1,121,243.62 task order falls under the NIAID Clinical Research Support Services 2017-2024 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract is for implementation, support, and oversight of a GCRSS VRC 612 site, as well as...
This is a federal contract award to The Emmes Company LLC, a for-profit limited liability company, by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID). The award, with a potential value of $171,669.34, is a delivery order under the NIAID Clinical Research Support Services 2017-2024 indefinite delivery, indefinite quantity (IDIQ) contract. The contract is for general clinical research support services, with...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company. The contract is a delivery order with a cost-plus-fixed-fee pricing type, with a ceiling value of $357,541.94 and a completion date of October 27, 2017. The Emmes Company LLC is a global clinical research organization that specializes in providing comprehensive support services for biomedical research,...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company. The contract is a delivery order with a cost-plus-fixed-fee pricing type, valued at $756,481.01, with an ultimate completion date of April 22, 2021. The Emmes Company LLC is a global clinical research organization that specializes in providing comprehensive support services for biomedical research,...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company. The contract, valued at $584,241.46, is a Cost Plus Fixed Fee delivery order with a final completion date of March 13, 2021. It is not set aside for any specific business type. The Emmes Company LLC is a clinical research organization that provides a wide range of services to federal agencies,...
The Department of Health and Human Services, Food and Drug Administration (FDA) awarded a firm-fixed-price delivery order contract worth $19,925.52 to The Emmes Company LLC, a for-profit limited liability company based in Rockville, Maryland. This contract is for clinical site monitoring services in human subjects research, with a period of performance through May 15, 2024. The Emmes Company LLC is a global clinical research organization that provides comprehensive research support services to...

This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to The Emmes Company LLC, a for-profit limited liability company. The contract is part of the VRC Clinical Monitoring Initiative 2017-2024 master indefinite delivery/indefinite quantity (IDIQ) contract and is for clinical monitoring services in support of the Vaccine Research Center (VRC). The 5-year delivery order has a potential value of $174,115.89 and a period of performance from May 1, 2019 to March 28, 2021, with a completion date of March 31, 2026. The contract is not set aside for a specific business type.

Generated 3/22/24, 11:45 PM